Vukašin Radulović participated at today’s IQVIA Pharma Market Forum on behalf of the company “Heliant” along with eminent representatives of international and domestic pharmaceutical and technological companies.
The company “IQVIA”, the organizer of this forum held at the Crowne Plaza Hotel in Belgrade, is a leading global provider of advanced analytics, technological solutions and clinical research services in the field of life sciences. It operates in more than 100 countries and has approximately 86,000 employees.
Participants in the IQVIA Pharma Market Forum panels discussed current trends in the global and Serbian pharmaceutical market, digital transformation in healthcare and enabling innovative ways of treating patients. They discussed how to make medicine more patient-oriented in reality, and/or how to strengthen healthcare in Serbia through patient-centred approaches.
Vukašin Radulović, a representative of the company “Heliant” participated in the panel discussion on the digital transformation of healthcare, which was opened by Michal Pilkiewicz, IQVIA’s general director for Ukraine, the Adriatic and Baltic regions.
Radulović spoke about how the company “Heliant” helped in the digital transformation of the healthcare system with innovative solutions in Serbia and the region, and how the data provided by the information systems of the company “Heliant” provided help in the field of healthcare and improved the treatment of patients.
In addition to Radulović and Pilkjevic, Jelena Bojović from the Centre for the Fourth Industrial Revolution and Miloš Milenković from the pharmaceutical company “Roche” also took part in the panel. The panel was moderated by Romanca Pekurari, commercial director for Serbia, Montenegro and Bosnia and Herzegovina at “IQVIA”.
Representatives of Hemofarm, MSD and Sandoz also spoke at the forum.